Australia Patent: Hanmi Pharm Files Application for 'Therapeutic use of long-acting conjugate of triple agonist having activity with respect to all of glucagon and GLP-1 and GIP receptors against lung disease'

Press/Media: Press / Media

Period2022 Sep 9

Media coverage

1

Media coverage

  • TitleAustralia Patent: Hanmi Pharm Files Application for 'Therapeutic use of long-acting conjugate of triple agonist having activity with respect to all of glucagon and GLP-1 and GIP receptors against lung disease'
    Media name/outletAustralian Government News (Ht Media)
    Country/TerritoryAustralia
    Date22/9/9
    Personsjin woo Park